Iron deficiency anemia due to abnormal uterine bleeding caused by uterine fibroids
Conditions
Interventions
Experimental group:Basic treatment + polysaccharide iron complex capsule (oral, 1 capsule/time, once a day)
Sponsors
Beijing Maternity Hospital Affiliated to Capital Medical University
Eligibility
Sex/Gender
Female
Age
20 Years to 55 Years
Inclusion criteria
Inclusion criteria: (1) Meet the relevant diagnostic criteria of iron deficiency anemia caused by abnormal uterine bleeding caused by uterine fibroids and belong to preoperative pretreatment patients; (2) Patients who received GNRH-a hemostatic treatment first, and at the same time were given oral "Yangxue Yin oral liquid" to treat anemia, and bleeding stopped; (3) Patients with mild to moderate anemia (mild to moderate anemia 60g/L=Hb<110g/L); (4) Aged between 20 and 55 (including endpoint values); (5) Voluntary signing of informed consent.
Exclusion criteria
Exclusion criteria: (1) Severely damaged liver and kidney function (liver function: ALT, AST more than 2 times the upper limit of normal value; Renal function: GFR < 60ml/min), especially in patients with untreated urinary tract infection; (2) Patients who have taken sex hormone drugs for treatment of other diseases within three months; (3) High iron load, haemochromatosis or hemosiderosis; (4) Patients with severe cardiovascular and cerebrovascular diseases (such as coronary atherosclerosis, cerebral hemorrhage, cerebral thrombosis, etc.); (5) Alcoholism, hepatitis, acute infection, intestinal inflammation, pancreatitis, gastric and duodenal ulcer, ulcerative enteritis; (6) Pregnant and lactating women; (7) Allergic to iron; (8) Patients with severe speech and cognitive impairment; (9) Participating in other drug clinical researchers; (10) Participation in clinical research is not considered appropriate by the research physician.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood routine index test: hemoglobin (Hb) and red blood cell count (RBC);Detection of four indexes of iron: serum iron (SI), transferrin (TRF), ferritin (SF), total iron binding capacity (TIBC); | — |
Countries
China
Contacts
Public ContactLu Dan
Beijing Maternity Hospital Affiliated to Capital Medical University
Outcome results
None listed